Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma (NCT03712202) | City of Hope Medical Center | 2018-11-28 |
Track Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.